Submission of Voting Results and Scrutinizer''s Report dated 25th April, 2026

Aptus Pharma Limited's shareholders have approved two resolutions via postal ballot voting that concluded on April 25, 2026. The first resolution approves an increase in the company's authorized share capital and corresponding changes to the Memorandum of Association. The second resolution approves the issuance of bonus shares in a 3:2 ratio, meaning shareholders will receive 3 new bonus equity shares for every 2 existing shares held. Both resolutions passed with 100% shareholder approval - all 51,22,000 votes cast were in favor with zero votes against. The promoter group holding 50,00,000 shares (approximately 73% of total) participated fully, while public shareholders had low participation with only 1,22,000 votes out of their 18,60,000 shares.